Transaction · 0002151661-26-000004

Jodar Luis

Jodar Luis, CMO, reported a transaction classified as grant at Vaxcyte, Inc. involving 88254.000000 shares for an estimated $0.00. Reported holdings after the transaction were 88254.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
PCVXVaxcyte, Inc.
Trade date
Sep 04, 2026
Filing date
Sep 09, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded88.2k$0.00 per share
Holdings after88.2kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

PCVX price since this filing

Daily closing prices, with the filing date and available return windows
PCVX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -6.0%1w ago +5.1%1d ago +2.8%
Returns since7d -1.2%30d +19.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0002151661-26-000004
Stock Option (right to buy)
Transaction date
Sep 04, 2026
Filed Sep 09, 2026, 09:40 PM · 5d delay
Shares
88,254 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
88,254 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as…

  2. to 1/4 of the shares subject to the award on September 7, 2027 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such dat…

  3. F2

    1/4 of the shares subject to the option shall vest on August 31, 2027, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through ea…

Original filing · 0002151661-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

PCVX